Global Healthcare Reimbursement

Healthcare Reimbursement Comprehensive Study by Type (Fully Paid, Partially Paid), Application (Physician Office, Hospitals, Diagnostic Laboratories, Others), Payer Types (Private Payers, Public Payers) Players and Region - Global Market Outlook to 2030

Healthcare Reimbursement Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Healthcare reimbursement is the payment that hospitals, diagnostic facilities, doctors, or different health care suppliers receive for providing medical service to individuals. Often, a government money handler or health insurance underwriter covers a person’s health care expenses partly or absolutely. Depending on the health insurance plan opted for, the person will claim the compensation cash from the insurance supplier. Typically, the payment is created when receiving medical service, that is why it's known as compensation. Advancement within the technology of electronic medical records (EMR) for observance of patient responsiveness, supplier application, and functioning of health care organizations have the potential to not solely strengthen the potency and accuracy of reimbursement mechanisms however additionally to refine the quality of medical aid.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledUnitedHealth Group (United States), CVS Health (United States), Aetna Inc. (United States), Aviva Life Insurance Company India Ltd. (India), Allianz (Germany), Reliance Nippon Life Insurance Company Limited (India), BNP Paribas (France) and WellCare Health Plans, Inc. (United States)


According to AMA, the market for Healthcare Reimbursement is expected to register a CAGR of 6.6% during the forecast period to 2030. This growth is primarily driven by Increasing Number of Surgeries Performed in Hospital Settings, Growing Geriatric Population Utilizing the Services of Hospitals and Rising demand for reimbursement policies that covers all the medical expense of the entire family..

Globally, a noticeable market trend is evident Increasing Adoption of The Insurance Policies The Financials sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as UnitedHealth Group (United States), CVS Health (United States), Aetna Inc. (United States), Aviva Life Insurance Company India Ltd. (India), Allianz (Germany), Reliance Nippon Life Insurance Company Limited (India), BNP Paribas (France) and WellCare Health Plans, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Key Developments in the Market:
In March 2019, Centern Corporation, a large publicly-traded company, and a multi-line managed care enterprise, acquired WellCare. The transaction will result in the establishment of a premier organization providing government-sponsored healthcare programs along with having expertise in Medicaid, Medicare, and the Health insurance marketplace.
In February 2024, Obscurity, a monthly subscription-led employee healthcare benefits provider, has launched “Claims Tracker” that will help over 10 lakh of its members effortlessly oversee their reimbursement claims in real-time.

Influencing Trend:
Increasing Adoption of The Insurance Policies

Market Growth Drivers:
Increasing Number of Surgeries Performed in Hospital Settings, Growing Geriatric Population Utilizing the Services of Hospitals and Rising demand for reimbursement policies that covers all the medical expense of the entire family.

Challenges:
A Rise in The Number of False Claims and Fraudulent activities associated with reimbursement policies

Restraints:
Resulting in Underpaid Settlements

Opportunities:
Growth of The Use of Technologies in The Reimbursement Procedure and Increasing healthcare expenditures and improvements in healthcare facilities

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Healthcare Reimbursement Market
- Analysis about New Entrants in Healthcare Reimbursement Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Healthcare Reimbursement Study Sheds Light on
— The Healthcare Reimbursement Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Healthcare Reimbursement industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Healthcare Reimbursement industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Fully Paid
  • Partially Paid
By Application
  • Physician Office
  • Hospitals
  • Diagnostic Laboratories
  • Others
By Payer Types
  • Private Payers
  • Public Payers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Surgeries Performed in Hospital Settings
      • 3.2.2. Growing Geriatric Population Utilizing the Services of Hospitals
      • 3.2.3. Rising demand for reimbursement policies that covers all the medical expense of the entire family.
    • 3.3. Market Challenges
      • 3.3.1. A Rise in The Number of False Claims
      • 3.3.2. Fraudulent activities associated with reimbursement policies
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of The Insurance Policies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Reimbursement, by Type, Application, Payer Types and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Healthcare Reimbursement (Value)
      • 5.2.1. Global Healthcare Reimbursement by: Type (Value)
        • 5.2.1.1. Fully Paid
        • 5.2.1.2. Partially Paid
      • 5.2.2. Global Healthcare Reimbursement by: Application (Value)
        • 5.2.2.1. Physician Office
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Diagnostic Laboratories
        • 5.2.2.4. Others
      • 5.2.3. Global Healthcare Reimbursement by: Payer Types (Value)
        • 5.2.3.1. Private Payers
        • 5.2.3.2. Public Payers
      • 5.2.4. Global Healthcare Reimbursement Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Healthcare Reimbursement (Price)
      • 5.3.1. Global Healthcare Reimbursement by: Type (Price)
  • 6. Healthcare Reimbursement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. UnitedHealth Group (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CVS Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aetna Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aviva Life Insurance Company India Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Allianz (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Reliance Nippon Life Insurance Company Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BNP Paribas (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. WellCare Health Plans, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Healthcare Reimbursement Sale, by Type, Application, Payer Types and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Healthcare Reimbursement (Value)
      • 7.2.1. Global Healthcare Reimbursement by: Type (Value)
        • 7.2.1.1. Fully Paid
        • 7.2.1.2. Partially Paid
      • 7.2.2. Global Healthcare Reimbursement by: Application (Value)
        • 7.2.2.1. Physician Office
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Diagnostic Laboratories
        • 7.2.2.4. Others
      • 7.2.3. Global Healthcare Reimbursement by: Payer Types (Value)
        • 7.2.3.1. Private Payers
        • 7.2.3.2. Public Payers
      • 7.2.4. Global Healthcare Reimbursement Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Healthcare Reimbursement (Price)
      • 7.3.1. Global Healthcare Reimbursement by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Reimbursement: by Type(USD Million)
  • Table 2. Healthcare Reimbursement Fully Paid , by Region USD Million (2018-2023)
  • Table 3. Healthcare Reimbursement Partially Paid , by Region USD Million (2018-2023)
  • Table 4. Healthcare Reimbursement: by Application(USD Million)
  • Table 5. Healthcare Reimbursement Physician Office , by Region USD Million (2018-2023)
  • Table 6. Healthcare Reimbursement Hospitals , by Region USD Million (2018-2023)
  • Table 7. Healthcare Reimbursement Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 8. Healthcare Reimbursement Others , by Region USD Million (2018-2023)
  • Table 9. Healthcare Reimbursement: by Payer Types(USD Million)
  • Table 10. Healthcare Reimbursement Private Payers , by Region USD Million (2018-2023)
  • Table 11. Healthcare Reimbursement Public Payers , by Region USD Million (2018-2023)
  • Table 12. South America Healthcare Reimbursement, by Country USD Million (2018-2023)
  • Table 13. South America Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 14. South America Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 15. South America Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 16. Brazil Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 17. Brazil Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 18. Brazil Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 19. Argentina Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 20. Argentina Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 21. Argentina Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 22. Rest of South America Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 25. Asia Pacific Healthcare Reimbursement, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 29. China Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 30. China Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 31. China Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 32. Japan Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 33. Japan Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 34. Japan Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 35. India Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 36. India Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 37. India Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 38. South Korea Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 39. South Korea Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 40. South Korea Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 41. Taiwan Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 42. Taiwan Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 43. Taiwan Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 44. Australia Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 45. Australia Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 46. Australia Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 50. Europe Healthcare Reimbursement, by Country USD Million (2018-2023)
  • Table 51. Europe Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 52. Europe Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 53. Europe Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 54. Germany Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 55. Germany Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 56. Germany Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 57. France Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 58. France Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 59. France Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 60. Italy Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 61. Italy Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 62. Italy Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 63. United Kingdom Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 66. Netherlands Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 67. Netherlands Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 68. Netherlands Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 69. Rest of Europe Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 72. MEA Healthcare Reimbursement, by Country USD Million (2018-2023)
  • Table 73. MEA Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 74. MEA Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 75. MEA Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 76. Middle East Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 77. Middle East Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 78. Middle East Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 79. Africa Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 80. Africa Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 81. Africa Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 82. North America Healthcare Reimbursement, by Country USD Million (2018-2023)
  • Table 83. North America Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 84. North America Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 85. North America Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 86. United States Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 87. United States Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 88. United States Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 89. Canada Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 90. Canada Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 91. Canada Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 92. Mexico Healthcare Reimbursement, by Type USD Million (2018-2023)
  • Table 93. Mexico Healthcare Reimbursement, by Application USD Million (2018-2023)
  • Table 94. Mexico Healthcare Reimbursement, by Payer Types USD Million (2018-2023)
  • Table 95. Healthcare Reimbursement: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Healthcare Reimbursement: by Type(USD Million)
  • Table 105. Healthcare Reimbursement Fully Paid , by Region USD Million (2025-2030)
  • Table 106. Healthcare Reimbursement Partially Paid , by Region USD Million (2025-2030)
  • Table 107. Healthcare Reimbursement: by Application(USD Million)
  • Table 108. Healthcare Reimbursement Physician Office , by Region USD Million (2025-2030)
  • Table 109. Healthcare Reimbursement Hospitals , by Region USD Million (2025-2030)
  • Table 110. Healthcare Reimbursement Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 111. Healthcare Reimbursement Others , by Region USD Million (2025-2030)
  • Table 112. Healthcare Reimbursement: by Payer Types(USD Million)
  • Table 113. Healthcare Reimbursement Private Payers , by Region USD Million (2025-2030)
  • Table 114. Healthcare Reimbursement Public Payers , by Region USD Million (2025-2030)
  • Table 115. South America Healthcare Reimbursement, by Country USD Million (2025-2030)
  • Table 116. South America Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 117. South America Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 118. South America Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 119. Brazil Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 120. Brazil Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 121. Brazil Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 122. Argentina Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 123. Argentina Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 124. Argentina Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 125. Rest of South America Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 126. Rest of South America Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 127. Rest of South America Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 128. Asia Pacific Healthcare Reimbursement, by Country USD Million (2025-2030)
  • Table 129. Asia Pacific Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 130. Asia Pacific Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 131. Asia Pacific Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 132. China Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 133. China Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 134. China Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 135. Japan Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 136. Japan Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 137. Japan Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 138. India Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 139. India Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 140. India Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 141. South Korea Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 142. South Korea Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 143. South Korea Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 144. Taiwan Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 145. Taiwan Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 146. Taiwan Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 147. Australia Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 148. Australia Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 149. Australia Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 150. Rest of Asia-Pacific Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 153. Europe Healthcare Reimbursement, by Country USD Million (2025-2030)
  • Table 154. Europe Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 155. Europe Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 156. Europe Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 157. Germany Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 158. Germany Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 159. Germany Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 160. France Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 161. France Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 162. France Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 163. Italy Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 164. Italy Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 165. Italy Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 166. United Kingdom Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 167. United Kingdom Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 168. United Kingdom Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 169. Netherlands Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 170. Netherlands Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 171. Netherlands Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 172. Rest of Europe Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 173. Rest of Europe Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 174. Rest of Europe Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 175. MEA Healthcare Reimbursement, by Country USD Million (2025-2030)
  • Table 176. MEA Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 177. MEA Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 178. MEA Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 179. Middle East Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 180. Middle East Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 181. Middle East Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 182. Africa Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 183. Africa Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 184. Africa Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 185. North America Healthcare Reimbursement, by Country USD Million (2025-2030)
  • Table 186. North America Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 187. North America Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 188. North America Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 189. United States Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 190. United States Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 191. United States Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 192. Canada Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 193. Canada Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 194. Canada Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 195. Mexico Healthcare Reimbursement, by Type USD Million (2025-2030)
  • Table 196. Mexico Healthcare Reimbursement, by Application USD Million (2025-2030)
  • Table 197. Mexico Healthcare Reimbursement, by Payer Types USD Million (2025-2030)
  • Table 198. Healthcare Reimbursement: by Type(USD/Units)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Reimbursement: by Type USD Million (2018-2023)
  • Figure 5. Global Healthcare Reimbursement: by Application USD Million (2018-2023)
  • Figure 6. Global Healthcare Reimbursement: by Payer Types USD Million (2018-2023)
  • Figure 7. South America Healthcare Reimbursement Share (%), by Country
  • Figure 8. Asia Pacific Healthcare Reimbursement Share (%), by Country
  • Figure 9. Europe Healthcare Reimbursement Share (%), by Country
  • Figure 10. MEA Healthcare Reimbursement Share (%), by Country
  • Figure 11. North America Healthcare Reimbursement Share (%), by Country
  • Figure 12. Global Healthcare Reimbursement: by Type USD/Units (2018-2023)
  • Figure 13. Global Healthcare Reimbursement share by Players 2023 (%)
  • Figure 14. Global Healthcare Reimbursement share by Players (Top 3) 2023(%)
  • Figure 15. Global Healthcare Reimbursement share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. UnitedHealth Group (United States) Revenue, Net Income and Gross profit
  • Figure 18. UnitedHealth Group (United States) Revenue: by Geography 2023
  • Figure 19. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 20. CVS Health (United States) Revenue: by Geography 2023
  • Figure 21. Aetna Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Aetna Inc. (United States) Revenue: by Geography 2023
  • Figure 23. Aviva Life Insurance Company India Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 24. Aviva Life Insurance Company India Ltd. (India) Revenue: by Geography 2023
  • Figure 25. Allianz (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Allianz (Germany) Revenue: by Geography 2023
  • Figure 27. Reliance Nippon Life Insurance Company Limited (India) Revenue, Net Income and Gross profit
  • Figure 28. Reliance Nippon Life Insurance Company Limited (India) Revenue: by Geography 2023
  • Figure 29. BNP Paribas (France) Revenue, Net Income and Gross profit
  • Figure 30. BNP Paribas (France) Revenue: by Geography 2023
  • Figure 31. WellCare Health Plans, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. WellCare Health Plans, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Global Healthcare Reimbursement: by Type USD Million (2025-2030)
  • Figure 34. Global Healthcare Reimbursement: by Application USD Million (2025-2030)
  • Figure 35. Global Healthcare Reimbursement: by Payer Types USD Million (2025-2030)
  • Figure 36. South America Healthcare Reimbursement Share (%), by Country
  • Figure 37. Asia Pacific Healthcare Reimbursement Share (%), by Country
  • Figure 38. Europe Healthcare Reimbursement Share (%), by Country
  • Figure 39. MEA Healthcare Reimbursement Share (%), by Country
  • Figure 40. North America Healthcare Reimbursement Share (%), by Country
  • Figure 41. Global Healthcare Reimbursement: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • UnitedHealth Group (United States)
  • CVS Health (United States)
  • Aetna Inc. (United States)
  • Aviva Life Insurance Company India Ltd. (India)
  • Allianz (Germany)
  • Reliance Nippon Life Insurance Company Limited (India)
  • BNP Paribas (France)
  • WellCare Health Plans, Inc. (United States)
Additional players considered in the study are as follows:
Agile Health Insurance (United States) , Blue Cross Blue Shield Association (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 178 Pages 50 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare Reimbursement Quantitative research analysis
Global Healthcare Reimbursement Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Healthcare Reimbursement market are UnitedHealth Group (United States), CVS Health (United States), Aetna Inc. (United States), Aviva Life Insurance Company India Ltd. (India), Allianz (Germany), Reliance Nippon Life Insurance Company Limited (India), BNP Paribas (France) and WellCare Health Plans, Inc. (United States), to name a few.
North America is dominating the Healthcare Reimbursement Market.
"A Rise in The Number of False Claims " is seen as one of the major challenges by many Industry Players of Healthcare Reimbursement Market
The Healthcare Reimbursement market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Healthcare Reimbursement market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Healthcare Reimbursement Report?

Have a Query? Click Here

Other Related Reports

Financial Advisory Comprehensive Study by Type (Accounting Advisory, Tax Advisory, Real Estate Advisory, Others), Application (Individual, Commercial (BFSI, Government, Healthcare, IT & telecom, Reta...
$ 3450
Online Alternative Investments Comprehensive Study by Type (Equity Crowdfunding, Private Equity, Physical Real Estate, Art Investment, Peer-to-Peer Lending, Commodities, Others), Application (Corpora...
$ 3450
Gig Economy Platforms Comprehensive Study by Type (APP-based, Website-based), By End User (Household Use, Commercial Use), By Industry Vertical (Freelancer, Independent Contractor, Part-Time, Project...
$ 3500
Outsource Debt Collection Services Comprehensive Study by Type (Customer Tracking and Data Validation Services, Early and Late-Stage Debt Collections, Debt Dispute Management Services, Debt Collectio...
$ 3750
Insurance Big Data Analytics Comprehensive Study by Type (Tools, Services), Application (Risk Assessment, Claim Assessment, Process Optimization, Client Management, Others), Organization Size (Large ...
$ 3750
Litigation Funding Investment Comprehensive Study by Type (Consumer Litigation Fund Investment, Commercial Litigation Fund Investment), Application (BSFI, IT and Telecommunication, Healthcare, Manufa...
$ 3500